RE:MBC phase 3Where did you find that 550 number of patients required for a Phase3 mBC trial? Are just pulling this number out of your hat and hope it sticks?
Adlai Nortye's US$85 million payment to ONCY will be triggered on the enrollment of the 50th patient into the pelareorep + paclitaxel Phase 3 mBC trial. ONCY has close to that number with inclusion of patients from the IND-213, BRACELET-1, and AN cross-over Phase 2 trials already completed.
That notwithstanding, I anticipate that a Big Pharma will be bidding on ONCY well beforehand.